GlassScriptPhysician profile
Jan Vazquez
NPI 1841889896
$3,438.96
in general payments reported to CMS, 2019-2025
12 companies · $2,120 in 2025
The $2,120 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $211 · 2023: $434 · 2024: $673 · 2025: $2,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,739 · Travel and Lodging: $1,399 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,739.13 |
| Travel and Lodging | $1,399.34 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,381.81 | 2025 | Interstim |
| Boston Scientific Corporation | $860.74 | 2022-2025 | Lumenis Pulse 120h, General - Kidney Stone Disease, Ams 700 |
| Teleflex LLC | $350.38 | 2023-2024 | Urolift |
| Janssen Pharmaceuticals, INC | $214.66 | 2024-2025 | Erleada, Rybrevant, Akeega |
| Verity Pharmaceuticals INC. | $160.28 | 2025 | Tlando |
| Ferring Pharmaceuticals INC. | $127.84 | 2024 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $123.55 | 2025 | |
| Pfizer INC. | $89.00 | 2023 | |
| Pbg Puerto Rico LLC | $60.35 | 2024-2025 | |
| Baxter Healthcare | $39.95 | 2025 | Tisseel |
| Pharmaand Gmbh | $15.20 | 2025 | Rubraca |
| Tolmar, INC. | $15.20 | 2025 | Rubraca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Vazquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.